These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2347057)

  • 21. Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.
    Manegold C; Worst P; Bickel J; Schmid H; Drings P; Kaufmann M
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S87-90. PubMed ID: 2112056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer.
    Leone BA; Vallejo CT; Romero AO; Perez JE; Cuevas MA; Lacava JA; Sabatini CL; Dominguez ME; Rodriguez R; Barbieri MR; Ortiz EH; Salvadori MA; Acuña LA; Acuña JM; Langhi MJ; Amato S; Machiavelli MR
    J Clin Oncol; 1996 Nov; 14(11):2993-9. PubMed ID: 8918497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines.
    Bellmunt J; Morales S; Navarro M; Solé LA
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S81-4. PubMed ID: 2347056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of two regimens of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer.
    Carmo-Pereira J; Costa FO; Henriques E; Carvalho V
    Cancer Chemother Pharmacol; 1986; 17(1):87-90. PubMed ID: 3516431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
    Ingle JN; Foley JF; Mailliard JA; Krook JE; Hartmann LC; Jung SH; Veeder MH; Gesme DH; Hatfield AK; Goldberg RM
    Cancer; 1994 May; 73(9):2337-43. PubMed ID: 8168039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours.
    Hoffmann W; Weidmann B; Migeod F; Könner J; Seeber S
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S69-70. PubMed ID: 2347053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
    Bunnell CA; Thompson L; Buswell L; Berkowitz R; Muto M; Sheets E; Shulman LN
    Cancer; 1998 Feb; 82(3):561-6. PubMed ID: 9452275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.
    Smith IE; Jones AL; O'Brien ME; McKinna JA; Sacks N; Baum M
    Eur J Cancer; 1993; 29A(12):1796-9. PubMed ID: 8398318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
    Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
    J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensified adjuvant cyclophosphamide, methotrexate and 5-fluorouracil therapy: a dose-finding study for ambulatory patients with breast cancer.
    Hietanen P; Teerenhovi L; Joensuu H
    Oncology; 1999; 56(2):103-9. PubMed ID: 9949294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
    Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
    J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prednimustine (Sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer.
    Yosef H; Slater A; Keen CW; Bunting JS; Hope-Stone H; Parmar H; Roberts JT; Termander B; Nilsson B
    Eur J Cancer; 1993; 29A(8):1100-5. PubMed ID: 8518020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
    Sanchiz F; Milla A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S91-2. PubMed ID: 2112057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
    Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber RD; Thürlimann B; Rudenstam CM
    Eur J Cancer; 1998 Oct; 34(11):1693-700. PubMed ID: 9893654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.